NCT04621903View on ClinicalTrials.gov

A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 8, 2020

Primary Completion Date

October 27, 2020

Study Completion Date

November 3, 2020

Conditions

Covid19

Interventions

OTHER

Shanshamani Vati Plus

Shanshamani Vati Plus was given as combination of Guduchi (Tinospora Cordifolia; 300 mg) and Pipli (Piper Longum 75 mg) twice daily.

Trial Locations (1)

Unknown

Aarogyam (UK) CIC, Leicester

All Listed Sponsors

collaborator

University of Warwick

OTHER

collaborator

All India Institute of Ayurveda, Ministry of AYUSH, Government of India

UNKNOWN

lead

Aarogyam UK

OTHER

NCT04621903 - A Pilot Study on Efficacy and Safety of Ayurveda Combination in Patients With Mild-to-Moderate COVID-19 | Biotech Hunter | Biotech Hunter